Nano-X Imaging (NNOX) to Release Earnings on Thursday

Nano-X Imaging (NASDAQ:NNOX) is projected to release its Q3 2025 results before the market opens on Thursday, November 20th. Analysts expect Nano-X Imaging to post earnings of ($0.1750) per share and revenue of $3.5050 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 20, 2025 at 8:30 AM ET.

Nano-X Imaging Trading Down 4.7%

Shares of NASDAQ:NNOX opened at $2.83 on Tuesday. The firm has a market cap of $163.51 million, a PE ratio of -3.14 and a beta of 1.97. The company has a fifty day simple moving average of $3.77 and a 200 day simple moving average of $4.51. Nano-X Imaging has a 12-month low of $2.78 and a 12-month high of $11.00.

Wall Street Analysts Forecast Growth

NNOX has been the subject of several research analyst reports. D. Boral Capital reissued a “buy” rating and issued a $8.00 target price on shares of Nano-X Imaging in a research report on Friday, September 19th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Thursday. Finally, Alliance Global Partners raised Nano-X Imaging to a “strong-buy” rating in a report on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $8.50.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets grew its stake in Nano-X Imaging by 193.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 11,994 shares of the company’s stock worth $62,000 after buying an additional 7,910 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Nano-X Imaging by 62.1% during the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after acquiring an additional 5,283 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Nano-X Imaging by 529.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock worth $71,000 after acquiring an additional 11,604 shares during the period. PharVision Advisers LLC acquired a new stake in shares of Nano-X Imaging in the 3rd quarter worth about $56,000. Finally, The Manufacturers Life Insurance Company lifted its position in Nano-X Imaging by 20.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock valued at $116,000 after purchasing an additional 3,818 shares during the last quarter. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.